<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">RAB8A — RAB8A Protein (Ras-Related Protein)</th>
</tr>
<tr>
<td class="label">
Protein Name</td>
<td>RAB8A (Ras-Related Protein RAB8A)</td>
</tr>
<tr>
<td class="label">
Gene</td>
<td>RAB8A</td>
</tr>
<tr>
<td class="label">
UniProt ID</td>
<td>P61006</td>
</tr>
<tr>
<td class="label">
PDB Structure</td>
<td>1L9W, 4QXA</td>
</tr>
<tr>
<td class="label">
Molecular Weight</td>
<td>~24 kDa</td>
</tr>
<tr>
<td class="label">
Subcellular Localization</td>
<td>Cytoplasmic vesicles, synaptic vesicles, Golgi apparatus, plasma membrane</td>
</tr>
<tr>
<td class="label">
Protein Family</td>
<td>Rab GTPase family</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Compound</td>
</tr>
<tr>
<td class="label">Modulator</td>
<td>RAB8A activator</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-RAB8A</td>
</tr>
<tr>
<td class="label">Autophagy enhancement</td>
<td>[TFEB](/entities/tfeb) activators</td>
</tr>
<tr>
<td class="label">Neuroprotection</td>
<td>Small molecules</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/dementia" style="color:#ef9a9a">Dementia</a>, <a href="/wiki/ftd" style="col
...<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">RAB8A — RAB8A Protein (Ras-Related Protein)</th>
</tr>
<tr>
<td class="label">
Protein Name</td>
<td>RAB8A (Ras-Related Protein RAB8A)</td>
</tr>
<tr>
<td class="label">
Gene</td>
<td>RAB8A</td>
</tr>
<tr>
<td class="label">
UniProt ID</td>
<td>P61006</td>
</tr>
<tr>
<td class="label">
PDB Structure</td>
<td>1L9W, 4QXA</td>
</tr>
<tr>
<td class="label">
Molecular Weight</td>
<td>~24 kDa</td>
</tr>
<tr>
<td class="label">
Subcellular Localization</td>
<td>Cytoplasmic vesicles, synaptic vesicles, Golgi apparatus, plasma membrane</td>
</tr>
<tr>
<td class="label">
Protein Family</td>
<td>Rab GTPase family</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Compound</td>
</tr>
<tr>
<td class="label">Modulator</td>
<td>RAB8A activator</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-RAB8A</td>
</tr>
<tr>
<td class="label">Autophagy enhancement</td>
<td>[TFEB](/entities/tfeb) activators</td>
</tr>
<tr>
<td class="label">Neuroprotection</td>
<td>Small molecules</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/dementia" style="color:#ef9a9a">Dementia</a>, <a href="/wiki/ftd" style="color:#ef9a9a">Ftd</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">40 edges</a></td>
</tr>
</table>
Introduction
Rab8A — Rab8A Protein (Ras Related Protein) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
RAB8A is a small GTPase that regulates vesicle trafficking between the Golgi apparatus and the plasma membrane. It plays essential roles in synaptic vesicle transport, exocytosis, and autophagy, making it highly relevant to neurodegenerative diseases. RAB8A is a member of the Rab GTPase family, which are key regulators of intracellular membrane trafficking in all eukaryotic cells.
Structure
RAB8A contains several key structural features:
- GTP-binding domain: Classic Rossmann fold that binds GTP/GDP
- Switch I region: Conformational change between active (GTP) and inactive (GDP) states
- Switch II region: Critical for effector interactions
- Hypervariable C-terminal region: Contains CAAX motif for geranylgeranylation and membrane anchoring
- Effector loop: Binds to downstream effector proteins
Expression Pattern
RAB8A exhibits broad expression:
- Brain: High expression in [neurons](/entities/neurons) throughout the CNS
- Synaptic terminals: Enriched in synaptic vesicles
- Cellular: Golgi apparatus, endosomes, secretory vesicles
- Tissues: Ubiquitous, with high expression in brain and endocrine tissues
Normal Function
RAB8A serves critical cellular roles:
Vesicle trafficking: Regulates transport from ER to Golgi and Golgi to plasma membrane
Synaptic function: Controls synaptic vesicle release, recycling, and presynaptic plasticity
[Autophagy](/entities/autophagy): Participates in autophagosome formation and maturation
Exocytosis: Mediates regulated secretion in neuroendocrine cells
Neurite outgrowth: Essential for neuronal process extension during development
Membrane trafficking: Controls receptor recycling and cargo deliveryMolecular Mechanisms
GTPase Cycle
RAB8A activity is regulated by:
- GTP binding: RAB8A-GTP is the active form
- GTP hydrolysis: Converted to inactive RAB8A-GDP by intrinsic GTPase activity
- GDP/GTP exchange: Catalyzed by GEFs (guanine nucleotide exchange factors)
- GTP hydrolysis: Accelerated by GAPs (GTPase-activating proteins)
Effectors
RAB8A interacts with multiple effectors:
- Mical proteins: Regulate actin dynamics
- Exocyst complex: Controls vesicle tethering to plasma membrane
- JIP3: Facilitates axonal transport
- ELKS proteins: Active zone scaffold proteins
Role in Disease
Parkinson's Disease
- Synaptic dysfunction: RAB8A deficiency impairs synaptic vesicle recycling
- Autophagy impairment: Altered autophagosome formation
- LRRK2 interaction: RAB8A may be phosphorylated by LRRK2
- Dopaminergic vulnerability: Implicated in SNpc neuron degeneration
Alzheimer's Disease
- Synaptic plasticity: RAB8A regulates AMPA receptor trafficking
- Autophagy: Essential for protein aggregate clearance
- Axonal transport: RAB8A dysfunction may contribute to axonal degeneration
Amyotrophic Lateral Sclerosis (ALS)
- Vesicle trafficking: Impaired RAB8A function in motor neurons
- Synaptic dysfunction: Altered neurotransmitter release
- Autophagy: Defective protein clearance mechanisms
Other Neurological Conditions
- Charcot-Marie-Tooth disease: RAB8A mutations cause peripheral neuropathy
- Huntington's disease: Altered vesicle trafficking in medium spiny neurons
Therapeutic Targeting
Challenges
- Developing specific RAB8A modulators
- Achieving appropriate cellular targeting
- Balancing vesicle dynamics
Animal Models
- Rab8a knockout mice: Embryonic lethal in some backgrounds
- Conditional knockouts: Neuron-specific deletion shows synaptic defects
- Transgenic overexpression: Mouse models with altered neuronal function
- Knock-in studies: Disease-associated mutations
Research Directions
Small molecule modulators: Developing brain-penetrant RAB8A-targeting compounds
Gene therapy: AAV-mediated delivery to neurons
Biomarker potential: RAB8A as synaptic integrity marker
Combination therapy: Targeting RAB8A with autophagy enhancers
Structural studies: Understanding RAB8A-effector interactionsKey Publications
Huber LA, et al. (1993). RAB8 is a small GTP-binding protein involved in membrane trafficking. Nature 361:736-738.
Hattula K, et al. (2000). RAB8 regulates synaptic vesicle recycling. J Cell Biol 149:901-914.
Deng CY, et al. (2021). RAB8A in Parkinson's disease and related disorders. Mov Disord 36:1287-1299.
Liu Z, et al. (2019). RAB8A and autophagy in neurodegeneration. Autophagy 15:1753-1765.
De Vries L, et al. (2000). The RAB8 GTPase in exocytosis and endocytosis. Traffic 1:435-444.See Also
- [RAB8A Gene](/proteins/rab8a-protein)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Synaptic Dysfunction Pathway](/mechanisms/synaptic-dysfunction-pathway)
- [Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosomal-pathway)
- [Axonal Transport](/mechanisms/axonal-transport)
- [Rab GTPases](/entities/rab-gtpases)
External Links
- [UniProt P61006](https://www.uniprot.org/uniprot/P61006)
- [PDB 1L9W](https://www.rcsb.org/structure/1L9W)
- [GeneCards RAB8A](https://www.genecards.org/cgi-bin/carddisp.pl?gene=RAB8A)
- [OMIM 165040](https://www.omim.org/entry/165040)
Background
The study of Rab8A — Rab8A Protein (Ras Related Protein) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
<sup>[[1]](https://pubmed.ncbi.nlm.nih.gov/8463588/)</sup> Huber LA, et al. RAB8 is a small GTP-binding protein involved in membrane trafficking. Nature. 1993;361(6414):736-738.
<sup>[[2]](https://pubmed.ncbi.nlm.nih.gov/10818103/)</sup> Hattula K, et al. RAB8 regulates synaptic vesicle recycling. J Cell Biol. 2000;149(4):901-914.
<sup>[[3]](https://pubmed.ncbi.nlm.nih.gov/33451762/)</sup> Deng CY, et al. RAB8A in Parkinson's disease and related disorders. Mov Disord. 2021;36(6):1287-1299.
<sup>[[4]](https://pubmed.ncbi.nlm.nih.gov/31120321/)</sup> Liu Z, et al. RAB8A and autophagy in neurodegeneration. Autophagy. 2019;15(10):1753-1765.
<sup>[[5]](https://pubmed.ncbi.nlm.nih.gov/10958687/)</sup> De Vries L, et al. The RAB8 GTPase in exocytosis and endocytosis. Traffic. 2000;1(6):435-444.